Dr. Siddhartha Ganguly
Claim this profileHouston Methodist Hospital
Area of expertise
Multiple Myeloma
Siddhartha Ganguly has run 5 trials for Multiple Myeloma. Some of their research focus areas include:
Mantle Cell Lymphoma
Siddhartha Ganguly has run 1 trial for Mantle Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Houston Methodist Hospital
Houston Methodist San Jacinto Hospital
Clinical Trials Siddhartha Ganguly is currently running
Iberdomide
for Multiple Myeloma
This phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric antigen receptor T-cell \[CAR-T\] therapy) for multiple myeloma. The usual approach after treatment with idecabtagene vicleucel is to monitor the multiple myeloma without giving myeloma medications. There is currently no medication approved specifically for use after idecabtagene vicleucel treatment. Upon administration, iberdomide modifies the immune system and activates immune cells called T-cells, which could enhance the effectiveness of idecabtagene vicleucel. Iberdomide may keep multiple myeloma under control for longer than the usual approach (disease monitoring) after idecabtagene vicleucel, and may help multiple myeloma patients live longer.
Recruiting
1 award
Phase 2
10 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting
2 awards
Phase 3
12 criteria
More about Siddhartha Ganguly
Clinical Trial Related
8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Siddhartha Ganguly has experience with
- Lenalidomide
- Idecabtagene Vicleucel
- Fludarabine
- Cyclophosphamide
- Autologous Hematopoietic Stem Cell Transplantation
- Rituximab
Breakdown of trials Siddhartha Ganguly has run
Multiple Myeloma
Mantle Cell Lymphoma
Plasma Cell Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Siddhartha Ganguly specialize in?
Siddhartha Ganguly focuses on Multiple Myeloma and Mantle Cell Lymphoma. In particular, much of their work with Multiple Myeloma has involved Stage III patients, or patients who are Stage IV.
Is Siddhartha Ganguly currently recruiting for clinical trials?
Yes, Siddhartha Ganguly is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Siddhartha Ganguly has studied deeply?
Yes, Siddhartha Ganguly has studied treatments such as Lenalidomide, Idecabtagene Vicleucel, Fludarabine.
What is the best way to schedule an appointment with Siddhartha Ganguly?
Apply for one of the trials that Siddhartha Ganguly is conducting.
What is the office address of Siddhartha Ganguly?
The office of Siddhartha Ganguly is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.